Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT00476112
Status:
COMPLETED
Last Update Posted:
2008-04-02
First Post:
2007-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Sponsor:
Advanz Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-18
First Submit QC Date:
None
Study First Post Date:
2007-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-31
Last Update Post Date:
2008-04-02
Last Update Post Date Type:
ESTIMATED